Sofosbuvir and Ribavirin for Hepatitis C in Patients With HIV Coinfection-Reference-Cited by-同舟云学术

Sofosbuvir and Ribavirin for Hepatitis C in Patients With HIV Coinfection

Published:2014-07-23 Issue:4 Volume:312 Page:353
ISSN:0098-7484
Container-title:JAMA
language:en
Short-container-title:JAMA

Author:

Sulkowski Mark S.¹,Naggie Susanna²,Lalezari Jacob³,Fessel Walford Jeffrey⁴,Mounzer Karam⁵,Shuhart Margaret⁶,Luetkemeyer Anne F.⁷,Asmuth David⁸,Gaggar Anuj⁹,Ni Liyun⁹,Svarovskaia Evguenia⁹,Brainard Diana M.⁹,Symonds William T.⁹,Subramanian G. Mani⁹,McHutchison John G.⁹,Rodriguez-Torres Maribel¹⁰,Dieterich Douglas¹¹

Affiliation:

1. Viral Hepatitis Center, Johns Hopkins University, Baltimore, Maryland

2. Duke Infectious Diseases, Duke University, Durham, North Carolina

3. Clinical Research, Quest Clinical Research, San Francisco, California

4. Internal Medicine, Kaiser Permanente, San Francisco, California

5. Philadelphia FIGHT, Philadelphia, Pennsylvania

6. Harborview Medical Center, University of Washington, Seattle

7. Division of HIV/AIDS, San Francisco General Hospital, University of California, San Francisco

8. Internal Medicine, University of California Davis Medical Center in Sacramento

9. Liver Disease Therapeutic Area, Gilead Sciences, Foster City, California

10. Fundacion De Investigacion San Juan, Puerto Rico

11. Department of Medicine–Liver Diseases, Mount Sinai School of Medicine, New York, New York

Publisher

American Medical Association (AMA)

Subject

General Medicine

Cited by 229 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Longitudinal Assessment of Multiple Immunological and Inflammatory Parameters during Successful DAA Therapy in HCV Monoinfected and HIV/HCV Coinfected Subjects;International Journal of Molecular Sciences;2022-10-08

2. Direct-Acting Antiviral Agents for Hepatitis C Virus Infection—From Drug Discovery to Successful Implementation in Clinical Practice;Viruses;2022-06-17

3. Curing Hepatitis C with Direct‐Acting Antiviral Therapy;New Drug Development for Known and Emerging Viruses;2021-12-03

4. Perioperative Management of Hepatitis C in Patients Undergoing Total Joint Arthroplasty;JBJS Reviews;2021-11

5. IL28B rs12979860 polymorphism and zinc supplementation affect treatment outcome and liver fibrosis after direct-acting antiviral hepatitis C therapy;Journal of Genetic Engineering and Biotechnology;2021-10-08